Company Overview
Snapshot
Founded in December 2022 by Ofer Barshem, Cell-Lipo operates with 1–10 employees. The company has secured funding across one round from PipelBiz. Cell-Lipo is currently in the Beta product stage, focusing on advancing its patent-protected medical device for stem cell isolation.
Business overview
Cell-Lipo is a Health Tech & Life Sciences company specializing in regenerative stem cell solutions. The company develops a patent-protected medical device that integrates advanced laser-assisted liposuction technology with a proprietary mechanical stem cell separation method. This technology aims to improve aesthetic treatments and offer relief for chronic disorders, serving the orthopedics market for conditions like osteoarthritis and sports injuries. Cell-Lipo's system provides a rapid, sterile, and cost-effective method for isolating stem cells from fat tissue, positioning itself as an alternative to enzymatic isolation methods.
Log in to access full profile ›Company Intelligence Q&A
- When was Cell-Lipo founded?
- Cell-Lipo was founded in December 2022.
- Who are the founders of Cell-Lipo?
- Ofer Barshem is a co-founder and CEO of Cell-Lipo.
- What is Cell-Lipo's primary focus?
- Cell-Lipo focuses on providing accessible, science-based regenerative stem cell solutions to improve aesthetic treatments and offer relief for chronic disorders.
- What is Cell-Lipo's core technology?
- Cell-Lipo's technology is based on laser liposuction and stem cell isolation for enhanced fat grafting and other non-aesthetic clinical applications. It uses a patent-protected device for rapid, simple, sterile, and cost-effective isolation of stem cells from fat tissue.
- What is the status of Cell-Lipo's product?
- Cell-Lipo's product is currently in the Beta stage. The company is advancing its patent-protected medical device for stem cell isolation, which integrates laser-assisted liposuction with a mechanical stem cell separation method.